PRLD Insider Transactions — Page 2
130 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 101–130; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Scherle Peggy | Chief Scientific Officer | 2021-04-07 | Sale | 6,881.0 | $39.63 |
| Scherle Peggy | Chief Scientific Officer | 2021-04-07 | Sale | 8,289.0 | $39.02 |
| Pierce Christopher | EVP and Chief of Business Oper | 2021-04-07 | Sale | 828.0 | $40.08 |
| Morosini Deborah | EVP, Chief of Clinical Affairs | 2021-04-07 | Sale | 1,000.0 | $40.04 |
| Mauro David J | Chief Medical Officer | 2021-04-07 | Sale | 7,083.0 | $39.69 |
| Mauro David J | Chief Medical Officer | 2021-04-07 | Sale | 8,300.0 | $39.03 |
| BAKER JULIAN | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| BAKER FELIX | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| 667, L.P. | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2020-09-29 | Purchase | 1,474,319.0 | $19.0 |
| BAKER JULIAN | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| BAKER FELIX | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| BAKER BROS. ADVISORS LP | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| Baker Brothers Life Sciences LP | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| 667, L.P. | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| Baker Bros. Advisors (GP) LLC | Director,TenPercentOwner | 2020-09-29 | Purchase | 104,628.0 | $19.0 |
| Combs Andrew | EVP, Head of Chemistry | 2020-09-29 | Purchase | 1,000.0 | $19.0 |
| Dier Mardi | Director | 2020-09-29 | Purchase | 10,000.0 | $19.0 |
| Morosini Deborah | EVP, Chief of Clinical Affairs | 2020-09-29 | Purchase | 444.0 | $19.0 |
| Pierce Christopher | EVP and Chief of Business Oper | 2020-09-29 | Purchase | 3,750.0 | $19.0 |
| Bonita David P | Director,TenPercentOwner | 2020-09-25 | Purchase | 710,500.0 | $19.0 |
| Bonita David P | Director,TenPercentOwner | 2020-09-25 | Purchase | 526,300.0 | $19.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 710,500.0 | $19.0 |
| ORBIMED CAPITAL LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 710,500.0 | $19.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 710,500.0 | $19.0 |
| ORBIMED ADVISORS LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 526,300.0 | $19.0 |
| ORBIMED CAPITAL LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 526,300.0 | $19.0 |
| OrbiMed Capital GP VI LLC | Director,TenPercentOwner | 2020-09-25 | Purchase | 526,300.0 | $19.0 |